Literature DB >> 6343782

Relationship between cytoplasmic and mitochondrial apparatus of protein synthesis in yeast Saccharomyces cerevisiae.

A P Surguchov, A B Sudarickov, M V Telckov, V N Smirnov, M D Ter-Avanesyan, S G Inge-Vechtomov.   

Abstract

A conditional respiratory deficiency in yeast Saccharomyces cerevisiae is expressed as a result of a nuclear mutation in sup1 and sup2 genes (II and IV chromosomes, respectively), coding for a component of cytoplasmic ribosomes (Ter-Avanesyan et al. 1982). One such strain is studied here in detail. The strain is temperature-dependent and expresses a respiratory deficient phenotype at 20 degrees C but not at 30 degrees C. Moreover, the strain is simultaneously chloramphenicol-dependent and is able to grow on media containing glycerol or ethanol as a sole carbon source only in the presence of the drug. Chloramphenicol has a differential effect on protein synthesis in mitochondria of the parent strain and the mutant. Since chloramphenicol is a ribosome-targeting antibiotic we suggest that the differential effect of the drug on parent and mutant mitochondrial protein synthesis is due to the altered properties of mito-ribosomes of the mutant compared to those of the parent strain. Mitochondria of the mutant synthesize all the mitochondrially encoded polypeptides, however, in significantly lowered amounts. A suggestion is put forward for the existence of a common component (a ribosomal protein) for mito and cyto-ribosomes.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6343782     DOI: 10.1007/bf00326073

Source DB:  PubMed          Journal:  Mol Gen Genet        ISSN: 0026-8925


  6 in total

1.  Analysis of products of mitochondrial protein synthesis in yeast: genetic and biochemical aspects.

Authors:  M Douglas; D Finkelstein; R A Butow
Journal:  Methods Enzymol       Date:  1979       Impact factor: 1.600

2.  Assembly of the mitochondrial membrane system. Characterization of nuclear mutants of Saccharomyces cerevisiae with defects in mitochondrial ATPase and respiratory enzymes.

Authors:  A Tzagoloff; A Akai; R B Needleman
Journal:  J Biol Chem       Date:  1975-10-25       Impact factor: 5.157

3.  Ribosomal recessive suppressors cause a respiratory deficiency in yeast Saccharomyces cerevisiae.

Authors:  M D Ter-Avanesyan; J Zimmermann; S G Inge-Vechtomov; A B Sudarikov; V N Smirnov; A P Surguchov
Journal:  Mol Gen Genet       Date:  1982

4.  Recessive suppression in yeast Saccharomyces cerevisiae is mediated by a ribosomal mutation.

Authors:  A P Surguchov; Y V Beretetskaya; E S Fominykch; E M Pospelova; M D Ter-Avanesyan; S G Inge-Vechtomov
Journal:  FEBS Lett       Date:  1980-02-25       Impact factor: 4.124

5.  Synergistic action of genetic and phenotypic suppression of nonsense mutations in yeast Saccharomyces cerevisiae.

Authors:  A P Surguchov; E M Pospelova; V N Smirnov
Journal:  Mol Gen Genet       Date:  1981

6.  The effect of paromomycin on the expression of ribosomal suppressors in yeast.

Authors:  L N Mironova; N A Provorov; M D Ter-Avanesyan; S G Inge-Vechtomov; V N Smirnov; A P Surguchov
Journal:  Curr Genet       Date:  1982-07       Impact factor: 3.886

  6 in total
  3 in total

1.  Immunologically related proteins in cytoplasmic and mitochondrial ribosomes of yeast Saccharomyces cerevisiae.

Authors:  A B Sudarickov; A P Surguchov
Journal:  Mol Gen Genet       Date:  1986-05

2.  Yeast omnipotent supressor SUP1 (SUP45): nucleotide sequence of the wildtype and a mutant gene.

Authors:  P Breining; W Piepersberg
Journal:  Nucleic Acids Res       Date:  1986-07-11       Impact factor: 16.971

3.  A Conserved Mito-Cytosolic Translational Balance Links Two Longevity Pathways.

Authors:  Marte Molenaars; Georges E Janssens; Evan G Williams; Aldo Jongejan; Jiayi Lan; Sylvie Rabot; Fatima Joly; Perry D Moerland; Bauke V Schomakers; Marco Lezzerini; Yasmine J Liu; Mark A McCormick; Brian K Kennedy; Michel van Weeghel; Antoine H C van Kampen; Ruedi Aebersold; Alyson W MacInnes; Riekelt H Houtkooper
Journal:  Cell Metab       Date:  2020-02-20       Impact factor: 27.287

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.